Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Ltd

- close price
  • Market Cap 0.00 Cr.
  • Current Price
  • High / Low /
  • Stock P/E 0.00
  • Book Value
  • Dividend Yield %
  • ROCE 48.6 %
  • ROE 52.2 %
  • Face Value 5.00

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 55.4%

Cons

  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2024
32
19
Operating Profit 13
OPM % 40%
0
Interest 1
Depreciation 1
Profit before tax 11
Tax % 25%
8
EPS in Rs 1.33
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
37 44 48 71
23 24 28 42
Operating Profit 14 20 19 29
OPM % 37% 46% 41% 41%
0 0 0 0
Interest 1 0 1 2
Depreciation 1 1 2 2
Profit before tax 12 18 17 25
Tax % 26% 26% 38% 25%
9 14 10 19
EPS in Rs 89.17 136.54 104.22 3.12
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 25%
TTM: 48%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 29%
TTM: 85%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 55%
Last Year: 52%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.99 0.99 0.99 31
Reserves 8 22 26 16
6 12 17 21
3 2 7 22
Total Liabilities 18 37 51 89
4 18 19 18
CWIP 0 0 0 7
Investments 0 0 0 5
14 18 32 58
Total Assets 18 37 51 89

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-1 24 3 9
-1 -16 -5 -15
3 5 -1 2
Net Cash Flow 0 13 -3 -5

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 65 8 104 170
Inventory Days 29 111 168 175
Days Payable 114 77 62 338
Cash Conversion Cycle -20 41 210 7
Working Capital Days 61 -52 -15 44
ROCE % 76% 45% 49%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Annual reports

No data available.